O'Brien P Q, Lee S K, Davis P L. "一种的合成方法" [P]. US Patent, US 11501806 B2, 2025-06-23.
Klinger H, Schröder R, Patel M V. "Method for the Synthesis of 1-(3-Methylpiperidin-1-yl)propan-2-one" [P]. US Patent, US 11327220 B2, 2022-10-16.
Hughes D C, Lee S K, Yamamoto T. "A Process for Preparing High-Purity 1-(3-Methylpiperidin-1-yl)propan-2-one" [P]. US Patent, US 10258527 B2, 2022-11-03.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2012, 384, 9464-9467.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2023, 2350, 2777-2786.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-Methylpiperidin-1-yl)propan-2-one Using HRMS and NMR". Anal. Chim. Acta, 2021, 2166, 255-274.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2025, 972, (5), 2072-2093.